MCM
IONS icon

Manchester Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Manchester Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$159 Sell
2
-3
-60% -$226 ﹤0.01% 1288
2026
Q1 		$376 Hold
5
– – ﹤0.01% 1254
2025
Q4 		$396 Sell
5
-1,243
-100% -$93.6K ﹤0.01% 1279
2025
Q3 		$81.6K Hold
1,248
– – 0.01% 461
2025
Q2 		$49.3K Hold
1,248
– – 0.01% 569
2025
Q1 		$37.7K Buy
1,248
+243
+24% +$7.96K ﹤0.01% 600
2024
Q4 		$35.1K Buy
1,005
+160
+19% +$5.98K ﹤0.01% 611
2024
Q3 		$33.9K Buy
845
+150
+22% +$6.98K ﹤0.01% 612
2024
Q2 		$33.1K Buy
695
+690
+13,800% +$28.3K ﹤0.01% 577
2024
Q1 		$217 Hold
5
– – ﹤0.01% 995
2023
Q4 		$253 Hold
5
– – ﹤0.01% 961
2023
Q3 		$227 Buy
+5
New +$206 ﹤0.01% 952
2021
Q1 		– Sell
-114
Closed -$6K – 711
2020
Q4 		$6K Buy
114
+8
+8% +$399 ﹤0.01% 520
2020
Q3 		$5K Buy
106
+5
+5% +$278 ﹤0.01% 452
2020
Q2 		$6K Hold
101
– – ﹤0.01% 501
2020
Q1 		$5K Hold
101
– – ﹤0.01% 492
2019
Q4 		$6K Hold
101
– – ﹤0.01% 484
2019
Q3 		$6K Hold
101
– – ﹤0.01% 478
2019
Q2 		$6K Hold
101
– – ﹤0.01% 516
2019
Q1 		$8K Buy
+101
New +$6.51K ﹤0.01% 576
2015
Q1 		– Sell
-4,304
Closed -$266K – 702
2014
Q4 		$266K Hold
4,304
– – 0.03% 291
2014
Q3 		$167K Buy
+4,304
New +$153K 0.02% 400
2014
Q2 		– Sell
-3,639
Closed -$157K – 1093
2014
Q1 		$157K Sell
3,639
-209
-5% -$10.1K 0.03% 402
2013
Q4 		$153K Hold
3,848
– – 0.02% 391
2013
Q3 		$144K Buy
+3,848
New +$115K 0.02% 398

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Manchester Capital Management's IONS Position: Q2 2026 in Review

Manchester Capital Management reduced its Ionis Pharmaceuticals (IONS) stake by 60% in Q2 2026, selling an estimated $226 and leaving 2 shares worth $159. The position accounts for ﹤0.01% of the portfolio, ranked #1288.

Manchester Capital Management first reported a position in IONS in Q3 2013 and has held it in 25 quarters since. The position peaked at $266K in Q4 2014. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Manchester Capital Management held 2 shares of Ionis Pharmaceuticals worth $159 as of Q2 2026.
  • Manchester Capital Management sold 3 Ionis Pharmaceuticals shares in Q2 2026, an estimated $226.
  • Ionis Pharmaceuticals made up ﹤0.01% of Manchester Capital Management's portfolio in Q2 2026, its #1288 holding.
  • Manchester Capital Management first reported a position in Ionis Pharmaceuticals in Q3 2013 and has held it in 25 quarters since.
  • Manchester Capital Management's Ionis Pharmaceuticals position peaked at $266K in Q4 2014.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.